Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’d say August man. But maybe IPIX paid the CRO a little more for analysis. Who knows. I’d say August tho.
That was a big deal last week for a topical cream for Psoriasis. I’ve been examining the data over the years and I believe Prurisol is going to be a blockbuster based on previous data. Obviously we will find out very soon, but if we do show a 30% or higher Pasi 75 rate I guarantee we gain blockbuster status within 2 years of market intro.
As PP showed and crunched numbers that brings IPIX share price into the 30’s. Alone. That is forgetting about Brilacidin and K
Right on the head. You called .57
Oily. Smell. Stains clothing. Yes messy.
Hopefully by then we are around 30-45 dollars.
I am. Big picture is always a brutal long wait of mostly downs and some ups for pre-rev bios. But that first validation and partnership always sets you free into orbit. We have so many additional partnership possibilities too.....so I am looking at big picture. 10 years was goal when started. Only 7 in....3 more to go and I’ll sell a few thousand shares.
It is. People crying over not even a penny drop. HALF PENNY. LOL
We will have 3 world altering announcements in the next 2.5 months imo. In ipix world that is.
Haaaaaa!!!! Here we go. Back to data must be bad. Remember when you said data must be terrible and mgmt know. No updates.
AND THEN......we got a DATA LOCK email. Meaning they just received the go ahead to look at the data. I’d say up almost 70% and barely any volume means Aspire is holding. Jmo
This is a full 2 weeks since data lock. We don’t know how much work the CRO already put in to the data collection and display. A simple topline could be released on Monday for all we know. I doubt it but time is flying. Phase 2b data is a big deal especially with an Apple to Apple comparison to Otezla.
Short term to now long term investor. We will see them become over 5% holders by December. IMO.
Are you SS?
Okay fine. Maybe I was a little over the top. But I feel otc investors are mostly short term and could care less about the phase2a strict criteria.
Bravo. All so true and 99.7% of investors do not understand how strong that statement is.
I’d say they know exactly what is on tap. Hence the degree of detail regarding the BD Agreement. They will make a ton of money holding to higher levels. Stairway to heaven.
Data Lock: JUNE 30th
Today: July 9th.
Tic toc.
BTD. P data and first License Deal.
We will see all 3 by Sept 30th
Making my way back too. Added 3xs my holding in 2018 alone. Thx to all that helped. The majority in the low 40’s.
Brilacidin OM will be partnered within next 80 days. Validation baby. Bring it!!!
Lol. Excellent. Tomorrow is 10 days since data lock. Time flys. Anticipation and flippers may start to pounce on this .60 share price. A powered phase 2b trial that is an apple to apple comparison to a Goliath like Otezla who by the way is on par to hit 2 billion dollars. Oral psoriasis drugs are king. I hope we crush Otezla!!!!!
Good day. After almost climbing 100% in a week we only gave back 8%
Next step up coming. ProbVly another 100% on BTD
I think we breakout.
BUSINESS DEVELOPMENT has been a key term for IPIX and Leo over the past 6 months or so. If you read several of the last Q's you will find a bold titled section under Managements Plan of Operation and you will find bolded "BUSINESS DEVELOPMENT ACTIVITIES"
Over the past months I have read emails to other shareholders from the company and Leo dropped "Business Development" in the majority of them. When shareholders asked what is the plan and what is the delay with P and all of the hard questions, his response was mostly "actively" working with the CRO but the majority of our time is Business Development efforts. As I read more and more it came to me after I read this snip from the Q that Business Development basically meant partnerships and moving the business along with collaborations.
Business Development Activities
The Company is engaged in discussions and negotiations regarding the out-licensing of its mid-stage, first-in-class clinical assets to global and/or specialty pharmaceutical companies who have expressed an interest in one or more assets in our pipeline. Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties.
Recently, we released results from our completed Phase 2 Brilacidin study on Oral Mucositis. The results have attracted inquiries, additional confidential disclosure agreements, and discussions with pharmaceutical companies.
Think about how fast ipix could become a powerhouse. All the years of Leo screaming watershed moment could be close.
Add a first deal for OM. Add board of directors to ipix from BP and nasdaq is a clinch. This could get out of hand fast on hype
Prurisol phase 2b data is now on the clock. We should see topline in the next 1-4 weeks. That alone may change everything. Imagine a 40-50% PASI 75. Imagine even a 25% pasi 75
I’m leaning towards +40% which IMO would lead to a 2 billion a year drug in the upcoming years
Okay. IMO I believe IPIX has extreme confidence in hitting all 3 milestones. As I’ve stated, this setup is dilution as it was previously but this way allows a bigger lump sum to change hands quickly and it more than anything is sparking excitement here. Which is perfect for you as you like the board chatter. I think it’s a stair stepping finance agreement that they know which milestone will hit in order. IMO.
IMO. B-OM deal is all but dried ink.
All right. I’ll give you +120 on that bet. Let’s agree though....BTD prior to deal for OM. That will add mucho dinero to deal package. IMO.
BTD will be first milestone. IMO. Then p results. Then deal. Place your bets......
Both are going to happen and we say ByeBye Scotty! Have your BP friend reach out to ipix and ask about BD and have him offer a deal. I bet there will be no discussion because the deal is done. Just need the ink to dry.
A deal takes this company to the nasdaq where it should be and we will get institutional support to steady the share price. IMO.
B-OM. BLUE SKY!
Thx. This part really gets me excited:
...”such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA”
I mean!!!!! It sounds like a deal is done and details are all but inked. They are telling us. 10’s of millions upfront. And the BP will take control and fund the phase 3 to nda. I mean......we are going to rise and fast. IMO.
Here is something interesting. So in the PR Agreement with Aspire:
· $2 million upon announcement of the Company entering into a licensing arrangement with a pharmaceutical company for any of the Company’s clinical assets that will include an initial payment to the Company of an amount in the double-digits millions of dollars.
http://www.ipharminc.com/press-release/2018/6/28/innovation-pharmaceuticals-announces-7-million-milestone-funding-agreement-with-aspire-capital
Here is from the Purchase Agreement
Provided that on or before September 30, 2018, the Company announces the BD Agreement, and provided that the closing price of the Common Stock on such Date of Announcement was equal to or greater than $0.50, then, on or before the second Business Day after the Company announces the BD Agreement, the Company shall sell to the Buyer, and the Buyer shall purchase from the Company, the Fourth Purchase Shares and the Buyer shall pay to the Company as the purchase price therefor, via wire transfer, Two Million Dollars ($2,000,000) (the “Fourth Purchase Shares Purchase Price”). At the Buyer’s discretion, in lieu of purchasing the Fourth Purchase Shares or part thereof, the Buyer may elect to purchase Pre-Funded Warrants. The price for each Pre-Funded Warrant purchased in lieu of Fourth Purchase Shares will be the result of multiplying (x) the number of warrant shares that the Buyer may purchase under such Pre-Funded Warrant by (y) a number equal to the Fourth Purchase Price reduced by $0.01. The exercise price for each warrant share will be $0.01, and the Fourth Purchase Shares Purchase Price shall be reduced by the aggregate exercise price for the Pre-Funded Warrants purchased in lieu of Fourth Purchase Shares.
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
https://www.bamsec.com/filing/147793218003269/4?cik=1355250
So to me ----- I think B-OM will be our first license deal!!! At first based on the PR and 8-K it makes it sound like any of the company's assets with a double digit million upfront could be in the works, but when you hammer it out into the details of the "BD" (Business Development) details it clearly states OM.
Interesting.
I grabbed 6k more so far today. Thanks Aspire or whomever. You won’t get them back until after the 3 milestones hit......maybe ;)
Correct. It would. However ipix probably needs 2-4 weeks to compile the data for topline. That is a soft guess. I actually believe we see BTD first based in the 1 million milestone. Less at lower is Leo’s thought. Imo
Prurisol is the key here imo to really unlock share price value. P and all rights are 100% owned by ipix. The 505b2 is a fantastic pathway and not only allows for a cheaper/smaller phase 3 but the extension in exclusivity for up to 5 years is again valued in the 100’s of millions if not billions.
For many that do not understand that; look at HUMIRA’s year by year value. A drug new to market always takes a few years to climb into a decent market share. But by the end...if it’s a great blockbuster drug, the value is at a peak and that’s when for Prurisol possible case the company adds 5 more years of exclusive rights keeping it off generic. My point again is those additional 3-5 years if granted are worth possibly billions in itself.
Something to keep an eye out for. $$$$$$$
If we see 50% and up PASI 75 - I guarantee it’s multiple of billions - especially for a 505 2b designation.
That’s a buyout for only Prurisol.
We will all see what happens over the next 3 months and then years to come. I got my money where my belief is. That’s all I care about. Adding 5k more on Thurs, maybe will get 10K more shares. Every share counts in this industry. When buyouts and deals happen overnight with 10-15 dollar gap ups
Correct. Or closer to correct. There is nothing hidden here the only question becomes at what prices do we hit these milestones. If we crawl to 2-3-4-5 etc and hit...it will limit shares. If we get BTD at say .60-.70 and share price rises to 1.50 ish and then P data crushes 30% pasi 75 and we hit 5 overnight that is much less shares and then collect a 50 million upfront partnership we all of a sudden are rolling big time. ;)
Gl
Also, IMO I think we may see BTD as the first milestone. If I know Leo he made that milestone the smallest to hit it first. Less dilution for that 1 million and it will prop share price even higher for the next milestone of P data. I think the finale is a huge partnership. Jmo
Just deposited 5k. Will clear on the 5th. I bought in the 3-4 dollar range. I’ll buy until Leo sells or I see one negative trial outcome.
ATLEAST triple that. IMO. If P hits above 30% PASI 75, besting Otezla and we receive BTD for OM and secure our first partner for double digit millions in upfront payments, I’d say we see $10 plus.
This has been beaten down for so long and it’s time to hit those milestones and uplist IMO.
Wow. What a last minute day. An extra 80k added to a green close?
10 minutes left and a great day. IMO
Agree. Prurisol data has the chance to set this thing off! Nobody knows the data, we just know previous trials and pre-clinical. All pointing to a favorable result. Tic toc bany
You sand bagging SOB - u r buying up all the shares.